- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glucose Parameters in Finland
Total 523 results
-
AstraZenecaCompletedDiabetesUnited States, Mexico, Argentina, Brazil, Puerto Rico, Russian Federation, Germany, Italy, Ukraine, India, Hungary, Poland, Philippines
-
Solvay PharmaceuticalsCompletedPatients With Metabolic SyndromeHungary, Canada, Finland, Italy, Netherlands, Norway, Poland, Romania, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Finland, Israel, Japan, New Zealand, Slovakia, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Netherlands, Hungary, France, Bulgaria, Canada, Romania
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Brazil, United Kingdom, Finland, Argentina, Canada, Mexico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Sweden, Latvia, Finland, Greece, Romania, Czechia, Puerto Rico
-
Diasome PharmaceuticalsCompleted
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 1United States
-
TakedaTerminatedType 2 DiabetesUnited States, Argentina, Mexico, Chile, Peru
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Croatia, Italy, Slovakia, Denmark, Macedonia, The Former Yugoslav Republic of, Norway, Russian Federation, Finland, France, Poland, Greece, Romania, Sweden, Czech Republic, Argentina
-
University of California, DavisEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDiabetic Ketoacidosis | Cerebral EdemaUnited States
-
Mannkind CorporationNo longer availableType 1 Diabetes | Type 2 DiabetesUnited States
-
PfizerCompletedDiabetes, Type 2Canada, United States, Korea, Republic of, Taiwan, Mexico, Hungary, Slovakia
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2United States, Chile, Hong Kong, Argentina, Austria, Brazil, Canada, Mexico, Peru, Puerto Rico, Philippines, Thailand, Russian Federation, Poland, Germany, Taiwan, Switzerland
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Sweden, United States, Mexico, South Africa, Russian Federation, France, Spain, Switzerland, Canada, Finland, New Zealand, Korea, Republic of, Thailand, Israel, Germany, Peru, Australia, Denmark, Italy, Ukraine, Greece, Puerto Rico, Guatemal... and more
-
Elixir PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Netherlands, Austria, Spain, France, Germany, Ireland, Switzerland, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Russian Federation, United Kingdom, France, Ukraine
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United Kingdom, Denmark, Canada, France, Netherlands, Austria, Israel, Finland, Russian Federation, Croatia, Bulgaria, Poland, Ireland, Spain, Norway, Greece, Argentina, Germany
-
Medtronic DiabetesRecruitingType 2 Diabetes Treated With InsulinUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Canada, Germany, Netherlands, Argentina, Finland, Serbia, Mexico
-
PfizerCompletedDiabetes Mellitus, Type 2Germany, Netherlands, Sweden, Poland, Belgium, Finland, France, Norway, Spain, Switzerland
-
Gan and Lee Pharmaceuticals, USAWithdrawnDiabetes Mellitus, Type 1United States, Spain, Hungary, Poland, Germany, Czechia
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
SanofiCompletedDiabetes Mellitus, Type 2Italy, Ireland, Spain, Greece, Finland, Romania, Brazil, United Kingdom, France, Switzerland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Brazil, India, Puerto Rico, Romania, Poland, Germany, Croatia, Korea, Republic of, Mexico, United Kingdom, South Africa, Spain, Canada, Argentina, Czech Republic, Finland, France, Slovakia
-
Hoffmann-La RocheCompletedDiabetesUnited States, Panama, Mexico, Canada, Estonia, Lithuania, Bulgaria, Romania, Latvia, Puerto Rico, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1India, Italy, United Kingdom, Finland, Japan, Argentina, Macedonia, The Former Yugoslav Republic of, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Canada, Spain, Switzerland, Argentina, Finland, Hungary, Russian Federation, Slovenia, Slovakia
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
Vanderbilt University Medical CenterMassachusetts General Hospital; Carelon ResearchActive, not recruitingDiabetes Mellitus | Peripheral Arterial DiseaseUnited States, Canada, Finland
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Russian Federation, United Kingdom, Vietnam, Germany, Hungary, Finland, Norway, Netherlands, Slovakia, India
-
AstraZenecaTerminatedType 2 DiabetesItaly, United Kingdom, Germany, Philippines, Malaysia, Sweden, Finland, Canada, India, Australia, Singapore
-
Diamyd Therapeutics ABTerminatedType 1 Diabetes MellitusFrance, Germany, Finland, Italy, Netherlands, Slovenia, Spain, Sweden, United Kingdom
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael, Poland, Switzerland, Argentina, India, Malaysia, South Africa, Taiwan, Finland, France, Turkey, Croatia, Italy, Bulgaria, Romania, Australia, Thailand, Greece, Brazil, Spain, Korea, Republic of, Czech Republic, Philippines
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, United States, Japan, Russian Federation, Spain, Canada, Germany, Latvia, Mexico, Brazil
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela
-
AstraZenecaTerminatedDiabetes Mellitus, Type 2United States, Spain, United Kingdom, Germany, Finland, Norway, Israel, Netherlands
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom